Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03JAA
|
|||
Former ID |
DAP000921
|
|||
Drug Name |
Glycodiazine
|
|||
Synonyms |
GLYMIDINE; Glidiazine; Glycodiazin; Glymidinum; Glycodiazin [German]; Gondafon (TN); N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide; N-(5-(2-Methoxyethoxy)-2-pyrimidinyl)benzenesulfonamide; N-(5-(2-Methoxyethoxy)-2-pyrimidinyl)benzenesulphonamide; N-(5-{[2-(methyloxy)ethyl]oxy}pyrimidin-2-yl)benzenesulfonamide; 2-Benzolsulfonamido-5-.beta.-methoxy-aethoxy-pyrimidine; 2-Benzolsulfonamido-5-beta-methoxy-aethoxy-pyrimidine; 2-Benzolsulfonamido-5-beta-methoxy-aethoxy-pyrimidine [German]; 5-beta-(Methoxyethoxy)-2-(phenylsulfonylamido)pyrimidine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Approved | [1] | |
Therapeutic Class |
Hypoglycemic Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H15N3O4S
|
|||
Canonical SMILES |
COCCOC1=CN=C(N=C1)NS(=O)(=O)C2=CC=CC=C2
|
|||
InChI |
1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16)
|
|||
InChIKey |
QFWPJPIVLCBXFJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 339-44-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:146188
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Inward rectifier potassium channel Kir1.2 (KCNJ10) | Target Info | Binder | [1] |
KEGG Pathway | Gastric acid secretion | |||
Reactome | Activation of G protein gated Potassium channels | |||
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | ||||
WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||
Potassium Channels |
References | Top | |||
---|---|---|---|---|
REF 1 | Coupling between proximal tubular transport processes. Studies with ouabain, SITS and HCO3-free solutions. Pflugers Arch. 1977 Apr 25;368(3):245-52. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.